Skip to content

Clinical trials

Breast Neoplasms trials in Luxembourg

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Country / region: Luxembourg Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20111
20121
20141
20171
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Unknown status2
Active, not recruiting1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Luxembourg Institute of Health2
Association Francaise pour la Recherche Thermale1
Centre Francois Baclesse, Luxembourg1
GERCOR - Multidisciplinary Oncology Cooperative Group1
Hoffmann-La Roche1
Janssen Research & Development, LLC1
Jules Bordet Institute1
Novartis1
Pfizer1
Stemline Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms11
Neoplasm Metastasis3
Fibrosis2
Colonic Neoplasms1
Endometrial Neoplasms1
Head and Neck Neoplasms1
Neoplasms1
Radiation Injuries1

Trials

Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.